Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · ProShares

RXL Performance & Returns History

Ticker RXL · · Holdings as of May 31, 2026

Expense ratio
0.95%$95/yr per $10k
5-yr return
+7.2%annualized
1-yr return
+19.7%as of Dec 2025
Net assets
$72.1Mall share classes
Holdings
70

Bottom line

How has RXL performed?

As of Dec 31, 2025, RXL returned +19.7% over the past year, +7.2% a year over five years, +12.6% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $32,900. Its five-year return beat 88% of health care sector funds we track. Its best quarter was +29.7% and its worst −28.9%.

Updated Dec 31, 2025

RXL annual returns by year

RXL calendar-year returns 2016: −8.9%; 2017: +46.0%; 2018: +5.4%; 2019: +38.9%; 2020: +19.2%; 2021: +47.8%; 2022: −15.1%; 2023: −3.2%; 2024: −2.7%; 2025: +19.7% −9% 2016 +46% 2017 +5% 2018 +39% 2019 +19% 2020 +48% 2021 −15% 2022 −3% 2023 −3% 2024 +20% 2025
Fund gain (+) Fund loss (−)
Year2025202420232022202120202019201820172016
RXL+19.7%−2.7%−3.2%−15.1%+47.8%+19.2%+38.9%+5.4%+46.0%−8.9%

Source: Fund prospectus bar chart (risk/return summary)

Growth of $10,000 in RXL

$10,000 invested at the start of 2016 would have been worth about $32,800 by the end of 2025, based on the fund's reported calendar-year returns.

YearReturnValue of $10,000
2025+19.7%$32,838
2024−2.7%$27,438
2023−3.2%$28,188
2022−15.1%$29,117
2021+47.8%$34,308
2020+19.2%$23,208
2019+38.9%$19,464
2018+5.4%$14,012
2017+46.0%$13,296
2016−8.9%$9,106

Trailing returns vs benchmark and category

1 yr5 yr10 yrSince inception
RXL+19.7%+7.2%+12.6%—
Health Care Sector median+14.5%+4.2%+7.9%—

Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com

Recent monthly returns

For the three months ending May 31, 2026, RXL returned −16.17%, −1.56%, +4.37% (oldest to newest), per SEC Form N-PORT.

Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.